These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD. Thornton Snider J, Luna Y, Wong KS, Zhang J, Chen SS, Gless PJ, Goldman DP. Curr Med Res Opin; 2012 Dec; 28(12):1959-67. PubMed ID: 23098081 [Abstract] [Full Text] [Related]
3. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease. Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L. Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915 [Abstract] [Full Text] [Related]
4. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking. Kiri VA, Fabbri LM, Davis KJ, Soriano JB. Respir Med; 2009 Jan; 103(1):85-90. PubMed ID: 18793832 [Abstract] [Full Text] [Related]
5. Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease. Lee TA, Weiss KB. Am J Respir Crit Care Med; 2004 Apr 01; 169(7):855-9. PubMed ID: 14711795 [Abstract] [Full Text] [Related]
6. Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD. Joo MJ, Au DH, Fitzgibbon ML, Lee TA. Respir Med; 2010 Feb 01; 104(2):246-52. PubMed ID: 19879745 [Abstract] [Full Text] [Related]
9. Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease. Pujades-Rodríguez M, Smith CJ, Hubbard RB. QJM; 2007 Aug 01; 100(8):509-17. PubMed ID: 17609226 [Abstract] [Full Text] [Related]
10. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Ernst P, Gonzalez AV, Brassard P, Suissa S. Am J Respir Crit Care Med; 2007 Jul 15; 176(2):162-6. PubMed ID: 17400730 [Abstract] [Full Text] [Related]
12. Inhaled corticosteroids in COPD and the risk of lung cancer. Lee YM, Kim SJ, Lee JH, Ha E. Int J Cancer; 2018 Nov 01; 143(9):2311-2318. PubMed ID: 29943812 [Abstract] [Full Text] [Related]
13. Economic impact of using inhaled corticosteroids without prior exacerbation among elderly patients with chronic obstructive pulmonary disorder. Chen S, Plauschinat CA, Wu N, Fraser K, Boulanger L. J Med Econ; 2011 Nov 01; 14(4):458-62. PubMed ID: 21651427 [Abstract] [Full Text] [Related]
17. Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD. Loke YK, Kwok CS, Singh S. Eur Respir J; 2010 May 01; 35(5):1003-21. PubMed ID: 19926743 [Abstract] [Full Text] [Related]
18. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD). Cecere LM, Slatore CG, Uman JE, Evans LE, Udris EM, Bryson CL, Au DH. COPD; 2012 Jun 01; 9(3):251-8. PubMed ID: 22497533 [Abstract] [Full Text] [Related]